The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer

Author:

Fjermeros Kamilla1ORCID,Ghannoum Salim2,Geisler Stephanie B.1ORCID,Bhargava Sameer13,Tahiri Andliena4,Klajic Jovana4,Lüders Torben45ORCID,Fongård Marie2,Nawaz Meh Sameen46,Bosnjak-Olsen Tatjana7,Buvarp Unn-Cathrin Edvardsen1,Johanna Rosenskiold Aino Katri1,Nguyen Nam Thi1,Sletbak Tone Tysko1,Seyedzadeh Manouchehr8,Selsås Knut9,Porojnicu Alina Carmen10,Skjerven Helle Kristine11ORCID,Hovda Tone12,Sahlberg Kristine Kleivi135,Torland Lilly Anne135,Lyngra Marianne14,Hammarström Clara Louise14,Hönigsperger Elma Bahonjic14,Noone John Christopher14,Mathiassen Silje14,Hurtado Antoni15,Goel Shom16ORCID,Koff Andrew17,Tekpli Xavier2,Kristensen Vessela N.25,Geisler Jürgen15ORCID

Affiliation:

1. Department of Oncology, Akershus University Hospital, Lørenskog, Norway

2. Department of Medical Genetics, Oslo University Hospital, Oslo, Norway

3. Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway

4. Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway

5. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway

6. Department of Health and Exercise, School of Health Sciences, Kristiania University College, Oslo, Norway

7. Novartis, Medical Affairs, Oslo, Norway

8. Department of Radiology, Akershus University Hospital, Lørenskog, Norway

9. Department of Endocrine & Breast Surgery, Akershus University Hospital, Lørenskog, Norway

10. Department of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway

11. Department of Breast & Endocrine Surgery, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway

12. Department of Radiology, Drammen Hospital, Vestre Viken Hospital Trust, Norway

13. Department of Research & Innovation, Vestre Viken Hospital Trust, Drammen, Norway

14. Department of Pathology, Akershus University Hospital, Lørenskog, Norway

15. Functional Genomics group & Molecular Pathology Unit, Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca), Campus Universitario Miguel de Unamuno s/n. 37007, Salamanca, Spain

16. Peter MacCallum Cancer Centre, Australia & The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

17. Program in Molecular Biology, Memorial Sloan Kettering Cancer Center & Weill Cornell Medical College, New York, NY USA

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3